Sprowl et al. demonstrated in breast cancer models treated with taxanes that docetaxel induced TNF-α, and resistant MCF-7TXT9/10 cells exhibited increased TNF-α production with heightened NF-kB binding. Here, NFKB1 is linked to breast carcinoma.